EVALUATION OF ARGATROBAN DOSE REQUIREMENTS IN CRITICALLY ILL PATIENTS

被引：0
|
作者：
Hashemipour, Zahra
Dehoorne-Smith, Michelle
Edwin, Stephanie
机构：
来源：
CRITICAL CARE MEDICINE | 2012年 / 40卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
958
引用
收藏
页码：U261 / U261
页数：1
相关论文
共 50 条
  • [1] What Is The Optimal Dose of Argatroban For The Critically Ill?
    Gleason, Vanessa
    Koenig, George
    Thomson, Lynda
    Delisle, Dennis
    Weinstein, Michael
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [2] Argatroban anticoagulation in critically ill patients
    Beiderlinden, Martin
    Treschan, Tanja A.
    Goerlinger, Klaus
    Peters, Juergen
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (05) : 749 - 754
  • [3] Evaluation of argatroban use in critically ill patients in a large, academic institution
    Glass, Maresa
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : A283 - A283
  • [4] Argatroban dosage in critically ill patients with HIT
    Baghdasarian, SB
    Singh, I
    Militello, MA
    Bartholomew, JR
    Begelman, SM
    [J]. BLOOD, 2004, 104 (11) : 493A - 493A
  • [5] Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
    Bachler, Mirjam
    Asmis, Lars M.
    Koscielny, Juergen
    Lang, Thomas
    Nowak, Hartmuth
    Paulus, Patrick
    Schewe, Jens-Christian
    von Heymann, Christian
    Fries, Dietmar
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (05) : 239 - 256
  • [6] Argatroban dosing requirements in extracorporeal life support and other critically ill populations
    Dingman, J. Spencer
    Smith, Zachary R.
    Coba, Victor E.
    Peters, Michael A.
    To, Long
    [J]. THROMBOSIS RESEARCH, 2020, 189 : 69 - 76
  • [7] Efficacy of Argatroban in Critically Ill Patients with Heparin Resistance: A Retrospective Analysis
    Treichl, Benjamin
    Bachler, Mirjam
    Lorenz, Ingo
    Friesenecker, Barbara
    Oswald, Elgar
    Schlimp, Christoph J.
    Pedross, Florian
    Fries, Dietmar
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (01): : 61 - 67
  • [8] PROLONGED EXCESS WE ANTICOAGULATION WITH ARGATROBAN USE IN CRITICALLY ILL PATIENTS
    Bennett, Stephanie
    Johnson, Michael
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (12) : U257 - U257
  • [9] POTENTIAL PROLONGED EFFECTS OF ARGATROBAN IN THE CRITICALLY ILL
    Diep, Uyen
    Glass, Maresa
    Alexander, Earnest
    Giarratano, Melissa
    Walker, Erica
    [J]. CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [10] ENERGY MEASUREMENTS AND REQUIREMENTS OF CRITICALLY ILL PATIENTS
    DAMASK, MC
    SCHWARZ, Y
    WEISSMAN, C
    [J]. CRITICAL CARE CLINICS, 1987, 3 (01) : 71 - 96
12345